Patents by Inventor Altaf Kassam

Altaf Kassam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene products differentially expressed in cancerous cells and their methods of use II
    Patent number: 8101349
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: January 24, 2012
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Pablo Dominguez Garcia, Altaf Kassam, George Lamson
  • Human genes and gene expression products
    Publication number: 20070243176
    Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.
    Type: Application
    Filed: July 7, 2003
    Publication date: October 18, 2007
    Inventors: Jaime Escobedo, Pablo Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Filippo Randazzo, George Lamson, Elizabeth Scott, Guozhong Zhang, Altaf Kassam, David Pot, Radoje Drmanac, Ivan Labat, Birgit Stache-Crain
  • Gene products differentially expressed in cancerous cells
    Publication number: 20060234246
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: September 2, 2004
    Publication date: October 19, 2006
    Inventors: Elizabeth Scott, George Lamson, Altaf Kassam, Guozhong Zhang, Doreen Sakamoto, Pablo Garcia, Theresa May, Giulia Kennedy, Sanmao Kang, Christoph Reinhard, Ann Jefferson
  • Human genes and gene expression products V
    Patent number: 7122373
    Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.
    Type: Grant
    Filed: May 13, 1999
    Date of Patent: October 17, 2006
    Assignee: Nuvelo, Inc.
    Inventors: Lewis T. Williams, Jaime Escobedo, Michael A. Innis, Pablo Dominguez Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Klaus Giese, Filippo Randazzo, Giulia C. Kennedy, David Pot, Altaf Kassam, George Lamson, Radoje Drmanac, Radomir Crkvenjakov, Mark Dickson, Snezana Drmanac, Ivan Labat, Dena Leshkowitz, David Kita, Veronica Garcia, Lee William Jones, Birgit Stache-Crain
  • Human genes and gene expression products II
    Patent number: 6964868
    Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.
    Type: Grant
    Filed: January 28, 1999
    Date of Patent: November 15, 2005
    Assignee: Nuvelo, Inc.
    Inventors: Lewis T. Williams, Jaime Escobedo, Michael A. Innis, Pablo Dominguez Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Klaus Giese, Filippo Randazzo, Giulia C. Kennedy, David Pot, Altaf Kassam, George Lamson, Radoje Drmanac, Radomir Crkvenjakov, Mark Dickson, Snezana Drmanac, Ivan Labat, Dena Leshkowitz, David Kita, Veronica Garcia, Lee William Jones, Birgit Stache-Crain
  • Gene products differentially expressed in cancerous cells and their methods of use II
    Publication number: 20050227917
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: February 12, 2004
    Publication date: October 13, 2005
    Inventors: Lewis Williams, Jaime Escobedo, Michael Innis, Pablo Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Klaus Giese, Filippo Randazzo, Giulia Kennedy, David Pot, Altaf Kassam, George Lamson, Zhijun He, Elizabeth Scott, Guozhong Zhang, Theresa May, Doreen Sakamoto, Radoje Drmanac, Radomir Crkvenjakov, Mark Dickson, Snezana Drmanac, Ivan Labat, Dena Leshkowitz, David Kita, Veronica Garcia, Lee Jones, Birgit Stache-Crain
  • Human genes and gene expression products XVI
    Publication number: 20040086913
    Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.
    Type: Application
    Filed: June 26, 2003
    Publication date: May 6, 2004
    Inventors: Lewis T. Williams, Jaime Escobedo, Michael A. Innis, Pablo Dominguez Garcia, Julie Sudduth Klinger, Christoph Reinhard, Zhijun He, Filippo Randazzo, Giulia C. Kennedy, David Pot, Altaf Kassam, George Lamson, Radjoe Drmanac, Mark Dickson, Ivan Labat, Lee William Jones, Birgit Stache-Crain
  • Human genes and gene expression products isolated from human prostate
    Publication number: 20030215803
    Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostics and therapeutics comprising such novel human polynucleotides, their corresponding genes or gene products, including probes, antisense nucleotides, and antibodies. The polynucleotides of the invention correspond to a polynucleotide comprising the sequence information of at least one of SEQ ID NOS: 1-1477. The polypeptides of the invention correspond to a polypeptide comprising the amino acid sequence information of at least one of SEQ ID NOS: 1478-1568.
    Type: Application
    Filed: December 7, 2001
    Publication date: November 20, 2003
    Inventors: Pablo Dominguez Garcia, Jaime Escobedo, Altaf Kassam, George Lamson, Elizabeth Scott, Radoje Drmanac, Radomir Crkvenjakov, Mark Dickson, Snezana Drmanac, Ivan Labat, Dena Leshkowitz, David Kita, Veronica Garcia, Lee William Jones, Birgit Stache-Crain
  • Human cyclin-dependent kinase (hPFTAIRE)
    Publication number: 20030166217
    Abstract: A human gene encoding a novel cyclin-dependent kinase termed hPFTAIRE and its expression products can be used to provide reagents and methods for detecting migrating or metastasizing cells. Compositions and methods for treating proliferative disorders and neoplasia are also provided.
    Type: Application
    Filed: May 22, 2002
    Publication date: September 4, 2003
    Applicant: Chiron Corporation
    Inventors: Christoph Reinhard, David Pot, Altaf Kassam, Tasha Marenbach, Lewis T. Williams
  • Human FGF gene and gene expression products
    Publication number: 20030113869
    Abstract: This invention relates to human fibroblast growth factor (FGF 98), and to variants thereof and to polynucleotides encoding FGF 98. The invention also relates to diagnostic and therapeutic agents related to the polynucleotides and proteins, including probes and antibodies.
    Type: Application
    Filed: April 17, 2001
    Publication date: June 19, 2003
    Inventors: Hui Cen, Pablo D. Garcia, Uta Grieshammer, Altaf Kassam, Pauline P. Lee, David Pot, Denis Gospodarowicz, Kathleen Martin
  • Human genes and gene expression products
    Publication number: 20030044783
    Abstract: This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.
    Type: Application
    Filed: March 9, 2001
    Publication date: March 6, 2003
    Inventors: Lewis T. Williams, Jaime Escobedo, Michael A. Innis, Pablo Dominguez Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Filippo Randazzo, Giulia C. Kennedy, David Pot, Altaf Kassam, George Lamson, Radjoe Drmanac, Mark Dickson, Ivan Labat, Lee William Jones, Birgit Stache-Crain
  • Mitogen-activated protein kinase kinase 7 (MKK7)
    Patent number: 6492112
    Abstract: A human gene encoding a novel mitogen-activated (MAP) kinase kinase, MKK7, provides methods and reagents for treating a variety of MKK7-mediated disorders, such as ischemic heart disease, kidney failure, oxidative liver damage, respiratory distress syndrome, heat and radiation burns, septic shock, autoimmune disorders, and inflammatory diseases. MKK7 reagents can also be used to induce or prevent apoptosis.
    Type: Grant
    Filed: December 7, 1998
    Date of Patent: December 10, 2002
    Assignee: Chiron Corporation
    Inventors: Christoph Reinhard, Altaf Kassam, David Pot
  • Polynucleotides encoding human cyclin-dependent kinase (hPFTAIRE)
    Patent number: 6432668
    Abstract: A human gene encoding a novel cyclin-dependent kinase termed hPFTAIRE and its expression products can be used to provide reagents and methods for detecting migrating or metastasizing cells. Compositions and methods for treating proliferative disorders and neoplasia are also provided.
    Type: Grant
    Filed: December 7, 1998
    Date of Patent: August 13, 2002
    Assignee: Chiron Corporation
    Inventors: Christoph Reinhard, David Pot, Altaf Kassam, Tasha Marenbach, Lewis T. Williams
  • Diagnostic and therapeutic methods using molecules differentially expressed in cancer cells
    Publication number: 20020076735
    Abstract: The invention provides materials and methods for determining the metastatic potential of a cell and for identifying cancerous cells by determining the presence or absence of one or more expression products of at least one gene that is differentially expressed between normal cells, nonmetastatic cells, cells of low metastatic potential, and cells of high metastatic potential.
    Type: Application
    Filed: May 10, 2001
    Publication date: June 20, 2002
    Inventors: Lewis T. Williams, Jaime Escobedo, Michael A. Innis, Pablo Dominguez Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Klaus Giese, Filippo Randazzo, Giulia C. Kennedy, David Pot, Altaf Kassam, George Lamson, Radoje Drmanac, Radomir Crkvenjakov, Mark Dickson, Snezana Drmanac, Ivan Labat, Dena Leshkowitz, David Kita, Veronica Garcia, Lee William Jones, Birgit Stache-Crain